tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

HALO Stock Latest News

PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo
The FlyPGR institution likely weakens Halozyme bull case scenario, says Wells Fargo
3d ago
MRK
HALO
Merck granted review of Halozyme patent claims by PTAB
PremiumThe Fly
Merck granted review of Halozyme patent claims by PTAB
3d ago
MRK
HALO
Halozyme’s Strategic Positioning and Market Potential Drive Buy Rating
PremiumRatings
Halozyme’s Strategic Positioning and Market Potential Drive Buy Rating
8d ago
HALO
Halozyme announces EC approval of Bristol Myers’ Opdivo developed with Enhanze
PremiumThe Fly
Halozyme announces EC approval of Bristol Myers’ Opdivo developed with Enhanze
9d ago
BMY
HALO
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
PremiumRatings
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
23d ago
HALO
Halozyme downgraded to Equal Weight from Overweight at Morgan Stanley
PremiumThe FlyHalozyme downgraded to Equal Weight from Overweight at Morgan Stanley
24d ago
HALO
Hold Rating Issued Amid Uncertainty in Drug Pricing Regulations Impacting Halozyme
Premium
Ratings
Hold Rating Issued Amid Uncertainty in Drug Pricing Regulations Impacting Halozyme
24d ago
HALO
UnitedHealth suspends outlook, Under Armour reports Q4 beat; Morning Buzz
Premium
The Fly
UnitedHealth suspends outlook, Under Armour reports Q4 beat; Morning Buzz
24d ago
BA
JD
Halozyme, J&J slide as analyst cuts rating on CMS draft guidance
PremiumThe Fly
Halozyme, J&J slide as analyst cuts rating on CMS draft guidance
24d ago
JNJ
HALO
Coinbase, Caterpillar upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Coinbase, Caterpillar upgraded: Wall Street’s top analyst calls
24d ago
BRO
CAT
Halozyme downgraded to Underperform from Market Perform at Leerink
PremiumThe Fly
Halozyme downgraded to Underperform from Market Perform at Leerink
24d ago
HALO
Cautious Optimism for Halozyme Amid Uncertainties: Hold Rating Maintained
PremiumRatings
Cautious Optimism for Halozyme Amid Uncertainties: Hold Rating Maintained
30d ago
HALO
Halozyme Therapeutics Reports Strong Earnings and Growth
PremiumCompany AnnouncementsHalozyme Therapeutics Reports Strong Earnings and Growth
30d ago
HALO
Halozyme’s Strong Financial Performance and Strategic Developments Justify Buy Rating with $75 Price Target
Premium
Ratings
Halozyme’s Strong Financial Performance and Strategic Developments Justify Buy Rating with $75 Price Target
1M ago
HALO
Buy Rating for Halozyme Amid Legal Battle with Merck: Potential Multi-Billion-Dollar Royalty Opportunity
Premium
Ratings
Buy Rating for Halozyme Amid Legal Battle with Merck: Potential Multi-Billion-Dollar Royalty Opportunity
1M ago
HALO
Halozyme’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
PremiumRatings
Halozyme’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
1M ago
HALO
Halozyme Therapeutics Reports Strong Q1 2025 Results
PremiumCompany Announcements
Halozyme Therapeutics Reports Strong Q1 2025 Results
1M ago
HALO
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
PremiumRatings
Halozyme’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
1M ago
HALO
Closing Bell Movers: Sarepta falls 21% after earnings and guidance cut
PremiumThe Fly
Closing Bell Movers: Sarepta falls 21% after earnings and guidance cut
1M ago
EA
AMD
Halozyme reports Q1 non-GAAP EPS $1.11, consensus 94c
PremiumThe FlyHalozyme reports Q1 non-GAAP EPS $1.11, consensus 94c
1M ago
HALO
Halozyme raises FY25 non-GAAP EPS view to $5.30-$5.70 from $4.95-$5.35
Premium
The Fly
Halozyme raises FY25 non-GAAP EPS view to $5.30-$5.70 from $4.95-$5.35
1M ago
HALO
Halozyme Therapeutics (HALO) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Halozyme Therapeutics (HALO) Q1 Earnings Cheat Sheet
1M ago
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >